Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|H8F4 CAR-T cells||H8F4 CAR-T cells are T-cells engineered to expressed a chimeric antigen receptor (CAR) directed against PR1/HLA-A2, which potentially results in decreased tumor growth (PMID: 27265873).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||leukemia||not applicable||H8F4 CAR-T cells||Preclinical - Cell culture||Actionable||In a preclinical study, h8F4 CAR-T cells induced lysis of leukemia cell lines expressing PR1/HLA-A2 in culture (PMID: 27265873).||27265873|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|